Case reports
Reiter's syndrome following intravesical BCG immunotherapy
M B Hogartha, S Thomasb, M H Seiferta, S M Tariqb
a Department of
Rheumatology, St Mary's Hospital, Praed Street, London W2 1NY, UK, b Department of Respiratory Medicine, St Mary's
Hospital
Correspondence to: Dr Hogarth m.b.hogarth{at}btinternet.com
Submitted 12 January
2000;
Accepted 19 April 2000
A 71 year old woman developed conjunctivitis, asymmetrical
oligoarthritis, and cystitis (Reiter's syndrome) secondary to
intravesical BCG treatment for transitional cell carcinoma of the
bladder. She received oral prednisolone, izoniazid, and pyridoxine and made a full recovery. Increasing use of BCG as immunotherapy will lead
to an increase in the incidence of BCG associated reactive arthritis.
Prompt recognition and early diagnosis will facilitate treatment and recovery.
Keywords: arthritis; BCG immunotherapy; Reiter's syndrome
© 2000 by The Fellowship of Postgraduate Medicine
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
